GO:0070130 negative regulation of mitochondrial translation: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070130 describes any process that stops, prevents, or reduces the rate of mitochondrial protein synthesis from mitochondrial mRNA.
• Mitochondrial translation is a key node in cellular quality control and metabolic adaptation, and its negative regulation is essential for matching protein synthesis to nutrient and stress conditions.
• Key regulators include RNA-binding proteins such as RBM43, which represses PGC1α translation and links mitochondrial output to STING signaling.
• Mitochondrial translation control is implicated in cancer drug resistance, cardiac remodeling, T cell memory, and disulfidptosis defense.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect causal roles of negative regulators of mitochondrial translation.
• Methods such as Ribo-seq, mitochondrial proteomics, and Seahorse respirometry are commonly used to measure the functional impact of negative regulation.
Description
Mitochondria contain their own genome and a dedicated translation machinery that synthesizes a small but essential set of hydrophobic inner-membrane proteins. The rate of this synthesis must be tightly controlled because excessive or imbalanced mitochondrial protein production can disrupt proteostasis, impair respiration, and trigger cell death. GO:0070130, negative regulation of mitochondrial translation, captures the processes that stop, prevent, or reduce the frequency, rate, or extent of mitochondrial protein synthesis. This term is increasingly relevant because mitochondrial translation is now recognized as a regulatory hub in ageing, immunity, cancer, and cardiac disease. Unlike general cytosolic translation, mitochondrial translation is controlled by a distinct set of RNA-binding proteins, proteases, and signaling pathways that respond to nutrient status, stress, and developmental cues. For example, RBM43 was shown to repress the translation of PGC1α, a master regulator of mitochondrial biogenesis, thereby linking mitochondrial output to an interferon-STING axis. In T cells, glucose limitation activates AMPK-coupled SENP1-Sirt3 signaling in mitochondria, which supports memory development and likely involves translational remodeling. These examples illustrate that negative regulation of mitochondrial translation is not a passive brake but an active, signal-responsive process. For researchers, GO:0070130 provides a framework to study how cells balance mitochondrial proteostasis with metabolic demand. Perturbations in this process have been linked to doxorubicin resistance in triple-negative breast cancer, pathological cardiac remodeling, and defense against disulfidptosis. Understanding the molecular players and regulatory logic of this term is therefore essential for both basic mitochondrial biology and therapeutic development.
negative regulation of mitochondrial translation At A Glance
| GO ID | GO:0070130 |
|---|---|
| GO term | negative regulation of mitochondrial translation |
| Ontology | biological_process |
| Synonym | negative regulation of mitochondrial protein anabolism; negative regulation of mitochondrial protein biosynthesis; negative regulation of mitochondrial protein formation; negative regulation of mitochondrial protein synthesis |
| Major function | Reduces the rate or extent of mitochondrial protein synthesis in response to cellular signals, stress, or metabolic state |
| Related processes | Mitochondrial gene expression, mitochondrial proteostasis, mitophagy, and metabolic adaptation |
| Cellular context | Mitochondrial matrix and inner membrane, with crosstalk to cytosolic signaling pathways |
| Disease relevance | Cancer drug resistance, cardiac hypertrophy, T cell memory, and disulfidptosis defense |
What Is GO:0070130?
GO:0070130 is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA in a mitochondrion. In simpler terms, it covers all mechanisms that put the brakes on mitochondrial protein synthesis, whether by degrading mitochondrial mRNAs, inhibiting mitochondrial ribosomes, limiting the availability of translation factors, or signaling from nutrient and stress pathways.
Why Is negative regulation of mitochondrial translation Important in Cell Biology?
Negative regulation of mitochondrial translation is important because mitochondria cannot simply make more proteins when stressed; they must coordinate synthesis with import, assembly, and degradation of respiratory chain components. Dysregulation of this balance contributes to ageing, metabolic disease, and cancer. For example, mitophagy, which removes damaged mitochondria, is intimately linked to mitochondrial quality control and ageing. In cardiac hypertrophy, mitochondrial function and protein synthesis are reprogrammed during pathological remodeling. In cancer, MALSU1-mediated regulation of mitochondrial function governs proliferation and doxorubicin resistance in triple-negative breast cancer cells. Thus, understanding GO:0070130 provides mechanistic insight into how cells adapt to stress and how this adaptation can be therapeutically targeted.
• Maintains mitochondrial proteostasis by preventing overproduction of hydrophobic inner-membrane proteins.
• Links nutrient sensing pathways such as AMPK to mitochondrial output and T cell memory.
• Modulates cell death pathways, including disulfidptosis, through translation of NRF2.
• Contributes to cancer drug resistance, as shown for MALSU1 in triple-negative breast cancer.
• Plays a role in cardiac remodeling and hypertrophy.
• Is connected to mitophagy and ageing through mitochondrial quality control.
• Can be hijacked by tumors to support proliferation under stress.
• Provides a target for CRISPR screens to identify new regulators.
• Helps explain how immune cells adapt to metabolic constraints.
• Offers a framework for understanding mitochondrial ribosomopathies and translation-related diseases.
What Happens During negative regulation of mitochondrial translation?
Signal sensing and initiation of repression
In simple terms: The cell senses stress or nutrient changes and decides to slow down mitochondrial protein production.
Negative regulation of mitochondrial translation often begins with signals such as glucose limitation, oxidative stress, or inflammatory cues. In T cells, glucose limitation activates AMPK coupled to SENP1-Sirt3 signaling in mitochondria, which supports memory development and likely involves translational remodeling. Similarly, RBM43 responds to cellular state to repress PGC1α translation, linking mitochondrial output to STING signaling. These examples show that repression is initiated by defined signaling inputs.
RNA-binding protein-mediated repression
In simple terms: Specific proteins bind mitochondrial mRNAs and block their translation.
RNA-binding proteins can directly inhibit translation of mitochondrial or mitochondria-related mRNAs. RBM43 controls PGC1α translation and a PGC1α-STING signaling axis, demonstrating that a single RNA-binding protein can coordinate mitochondrial biogenesis with immune signaling. This mode of regulation allows rapid, transcript-specific control without degrading the mRNA.
Mitoribosome inhibition and factor sequestration
In simple terms: The mitochondrial ribosome itself can be slowed down or its helper factors can be withheld.
Negative regulation can occur at the level of the mitoribosome or its accessory factors. MALSU1-mediated regulation of mitochondrial function governs proliferation and doxorubicin resistance in triple-negative breast cancer cells, indicating that mitoribosome-associated factors can modulate translation output. Such mechanisms may involve sequestration or modification of translation initiation and elongation factors.
Integration with mitochondrial quality control
In simple terms: When translation is reduced, the cell also adjusts mitophagy and protein degradation.
Reduced mitochondrial translation is often coupled to mitophagy and proteostatic responses. Mitophagy in human health, ageing and disease highlights how mitochondrial quality control is essential for cellular homeostasis. Negative regulation of translation may serve as a first line of defense, reducing the burden of misfolded proteins before mitophagy is engaged.
Downstream metabolic and transcriptional consequences
In simple terms: Slowing mitochondrial translation changes metabolism and gene expression.
Repression of mitochondrial translation reshapes cellular metabolism. For example, OGDH defends against disulfidptosis by licensing METTL3-regulated NRF2 translation, showing that mitochondrial enzymes and translation are intertwined with stress defense. In cardiac hypertrophy, mitochondrial remodeling is part of a broader transcriptional and metabolic reprogramming. These downstream effects can feed back to further modulate translation.
Key Genes Involved in GO:0070130 negative regulation of mitochondrial translation
The following genes and proteins have been experimentally linked to negative regulation of mitochondrial translation or related mitochondrial quality control processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RBM43 | RNA-binding protein that represses PGC1α translation and links to STING signaling | Studying mitochondrial biogenesis and immune-metabolic crosstalk |
| PGC1α (PPARGC1A) | Master regulator of mitochondrial biogenesis; its translation is controlled by RBM43 | Target for metabolic and mitochondrial function studies |
| MALSU1 | Mitoribosome assembly factor; regulates mitochondrial function and doxorubicin resistance | Cancer drug resistance and mitochondrial translation |
| SENP1 | DeSUMOylase involved in AMPK-coupled mitochondrial signaling in T cells | T cell memory and metabolic adaptation |
| Sirt3 (SIRT3) | Mitochondrial deacetylase in AMPK-coupled signaling | Mitochondrial metabolism and stress responses |
| AMPK | Energy sensor that coordinates mitochondrial translation with nutrient status | Metabolic regulation and T cell memory |
| OGDH | Mitochondrial enzyme that supports NRF2 translation via METTL3 | Disulfidptosis defense and redox regulation |
| METTL3 | RNA methyltransferase that regulates NRF2 translation | Epitranscriptomic control of translation |
| NRF2 (NFE2L2) | Transcription factor whose translation is regulated by METTL3 and OGDH | Oxidative stress response |
| MCU | Mitochondrial calcium uniporter; elevated expression limits pathological cardiac remodeling | Cardiac hypertrophy and calcium signaling |
| CaMKIIδB | Kinase that regulates MCU expression | Cardiac remodeling |
| KLHL6 | Ubiquitin ligase that drives resistance to CD8+ T cell dysfunction | T cell exhaustion and immunotherapy |
| Mitophagy machinery (e.g., PINK1, Parkin) | Mediates removal of damaged mitochondria | Ageing and mitochondrial quality control |
| mitoribosome proteins | Execute mitochondrial translation and are targets of regulation | Mitochondrial gene expression |
| Translation initiation factors (mitochondrial) | Control the rate of mitochondrial protein synthesis | Mechanistic studies of translation control |
| STING | Immune signaling adaptor linked to PGC1α translation | Innate immunity and mitochondrial stress |
| Sirtuins | NAD+-dependent deacetylases involved in mitochondrial stress responses | Metabolic regulation and ageing |
How Is negative regulation of mitochondrial translation Regulated?
Negative regulation of mitochondrial translation is controlled by multiple signaling pathways. AMPK, a central energy sensor, is activated by glucose limitation and couples to SENP1-Sirt3 signaling in mitochondria to support T cell memory development. RBM43 represses PGC1α translation and connects mitochondrial output to STING signaling, providing a direct link between RNA-binding proteins and immune-metabolic regulation. In cancer, MALSU1-mediated regulation of mitochondrial function governs proliferation and doxorubicin resistance, suggesting that mitoribosome assembly factors can be regulated by oncogenic pathways. Additionally, OGDH and METTL3 regulate NRF2 translation, integrating mitochondrial metabolism with epitranscriptomic control. These examples illustrate that negative regulation is not a single pathway but a network of nutrient, stress, and immune signals.
negative regulation of mitochondrial translation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MALSU1 | Triple-negative breast cancer doxorubicin resistance | Knockout and overexpression in TNBC cell lines |
| RBM43 | Metabolic and immune signaling via PGC1α-STING | Knockout and tagged knock-in in immune cells |
| MCU | Pathological cardiac remodeling | Cardiomyocyte-specific knockout or overexpression |
| SENP1/Sirt3 | T cell memory development | Knockout mice and T cell culture |
| OGDH | Disulfidptosis defense | Knockout and point-mutation models |
Cancer drug resistance
MALSU1-mediated regulation of mitochondrial function governs proliferation and doxorubicin resistance in triple-negative breast cancer cells, indicating that negative regulation of mitochondrial translation can be co-opted by tumors to survive chemotherapy. Targeting this axis may sensitize resistant cells.
Cardiac hypertrophy and remodeling
Pathological cardiac hypertrophy involves reprogramming of mitochondrial function and protein synthesis. Elevated MCU expression by CaMKIIδB limits pathological cardiac remodeling, showing that mitochondrial calcium and translation-related processes are intertwined in heart disease.
T cell memory and immunotherapy
Glucose limitation activates AMPK-coupled SENP1-Sirt3 signaling in mitochondria for T cell memory development, linking mitochondrial translation control to immune memory. KLHL6 drives resistance to CD8+ T cell dysfunction, further highlighting the importance of mitochondrial quality control in T cell exhaustion.
Ageing and mitochondrial quality control
Mitophagy in human health, ageing and disease underscores the role of mitochondrial quality control in ageing. Negative regulation of mitochondrial translation may act upstream of mitophagy to reduce proteotoxic stress and extend healthspan.
From negative regulation of mitochondrial translation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene increase mitochondrial translation? | CRISPR knockout in HEK293T or HeLa cells followed by Ribo-seq |
| Does a specific phosphorylation site regulate a translation repressor? | Point-mutation knock-in of phospho-dead or phospho-mimetic alleles |
| Does a disease-associated variant affect mitochondrial translation? | Knock-in of the variant in isogenic cell lines |
| Where does a repressor localize and interact? | Tagged knock-in (e.g., GFP or HA) for imaging and immunoprecipitation |
| Does overexpression of a repressor reduce mitochondrial protein synthesis? | Doxycycline-inducible overexpression in cancer cell lines |
| Which genes regulate mitochondrial translation under stress? | Genome-wide CRISPR library screening with mitochondrial translation reporters |
How to Study the negative regulation of mitochondrial translation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy on mitochondrial mRNAs | Quantifying translation rates after gene perturbation |
| Mitochondrial proteomics | Abundance of mitochondrial proteins | Validating translation changes at the protein level |
| Seahorse respirometry | Oxygen consumption rate and glycolysis | Assessing functional impact on oxidative phosphorylation |
| Fluorescent translation reporters | Real-time mitochondrial translation | Live-cell imaging of translation dynamics |
| CRISPR knockout screens | Gene essentiality and resistance | Identifying regulators of mitochondrial translation |
| Immunoprecipitation and mass spectrometry | Protein-protein interactions | Finding translation repressor complexes |
| Polysome profiling | Distribution of mRNAs across polysomes | Confirming translation repression |
| Mitochondrial isolation and western blot | Levels of mitochondrial proteins | Validating candidate regulators |
Ribo-seq and mitochondrial ribosome profiling
Ribosome profiling (Ribo-seq) measures ribosome occupancy on mitochondrial mRNAs, providing a direct readout of translation rates. This method can detect changes in mitochondrial translation upon knockout or overexpression of candidate regulators.
Mitochondrial proteomics and respirometry
Mass spectrometry-based proteomics quantifies mitochondrial protein abundance, while Seahorse respirometry measures oxidative phosphorylation. Together, they link negative regulation of translation to functional outcomes.
Imaging and reporter assays
Fluorescent reporters targeted to mitochondria can visualize translation in live cells. Tagged knock-in of translation factors allows tracking of localization and dynamics.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout or activation screens with mitochondrial translation reporters can identify novel negative regulators. Such screens have been used to uncover genes controlling T cell dysfunction and drug resistance.
How CRISPR Can Be Used to Study GO:0070130 negative regulation of mitochondrial translation
Knockout
CRISPR knockout of candidate negative regulators can de-repress mitochondrial translation, leading to increased mitochondrial protein synthesis. This approach is useful to test causality, as shown for MALSU1 in breast cancer cells and for genes identified in screens.
Point Mutation
Point mutations can be introduced to disrupt specific regulatory sites, such as phosphorylation or ubiquitination sites, without deleting the entire protein. This helps dissect signaling pathways controlling mitochondrial translation.
Knock-in
Knock-in of disease-associated variants or tagged alleles allows study of their impact on mitochondrial translation in an isogenic background. Tagged knock-in also enables localization and interaction studies.
Overexpression
Overexpression of a candidate repressor can reduce mitochondrial translation and phenocopy stress conditions. Inducible systems allow temporal control to avoid adaptation.
How EDITGENE Supports negative regulation of mitochondrial translation Research
Researchers studying negative regulation of mitochondrial translation-related genes often need to determine whether a candidate gene is causally involved in repressing mitochondrial protein synthesis, and whether this repression affects disease-relevant phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of mitochondrial translation research.
Frequently Asked Questions About negative regulation of mitochondrial translation
What is GO:0070130?
GO:0070130 is the Gene Ontology term for negative regulation of mitochondrial translation, describing any process that stops, prevents, or reduces the rate of protein synthesis in mitochondria.
What genes are involved in negative regulation of mitochondrial translation?
Key genes include RBM43, MALSU1, PGC1α, SENP1, Sirt3, AMPK, OGDH, METTL3, and NRF2, among others.
How is mitochondrial translation negatively regulated?
It is regulated by RNA-binding proteins, mitoribosome assembly factors, nutrient-sensing pathways like AMPK, and epitranscriptomic modifications.
Why is negative regulation of mitochondrial translation important in cancer?
It can promote drug resistance, as shown for MALSU1 in triple-negative breast cancer, and supports proliferation under stress.
What methods are used to study negative regulation of mitochondrial translation?
Common methods include Ribo-seq, mitochondrial proteomics, Seahorse respirometry, fluorescent reporters, and CRISPR screens.
Which diseases are linked to dysregulated mitochondrial translation?
Cancer, cardiac hypertrophy, T cell dysfunction, and ageing-related diseases have been linked to mitochondrial translation control.
How does AMPK regulate mitochondrial translation?
Glucose limitation activates AMPK coupled to SENP1-Sirt3 signaling in mitochondria, which supports T cell memory and likely involves translational remodeling.
What is the role of RBM43 in mitochondrial translation?
RBM43 represses PGC1α translation and links mitochondrial output to STING signaling.
Can CRISPR be used to study negative regulation of mitochondrial translation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect causal roles of candidate regulators.
What is the connection between mitophagy and mitochondrial translation?
Mitophagy removes damaged mitochondria, and negative regulation of translation may act upstream to reduce proteotoxic stress, as reviewed in ageing and disease.
Conclusion
GO:0070130, negative regulation of mitochondrial translation, is a critical biological process that balances mitochondrial protein synthesis with cellular stress and metabolic demands. Its dysregulation is implicated in cancer drug resistance, cardiac disease, immune dysfunction, and ageing. Understanding the molecular players and regulatory mechanisms provides opportunities for therapeutic intervention. EDITGENE offers comprehensive CRISPR services to accelerate research in this field.
References
- 1. Picca A et al.. 2023. Mitophagy in human health, ageing and disease.. Nat Metab 5(12):2047-2061 PMID: 38036770
- 2. Nakamura M et al.. 2018. Mechanisms of physiological and pathological cardiac hypertrophy.. Nat Rev Cardiol 15(7):387-407 PMID: 29674714
- 3. Cheng H et al.. 2026. The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction.. Nature 651(8105):451-461 PMID: 41535474
- 4. Dumesic PA et al.. 2025. RBM43 controls PGC1α translation and a PGC1α-STING signaling axis.. Cell Metab 37(3):742-757.e8 PMID: 39965564
- 5. Wang P et al.. 2022. Elevated MCU Expression by CaMKIIδB Limits Pathological Cardiac Remodeling.. Circulation 145(14):1067-1083 PMID: 35167328
- 6. He J et al.. 2021. Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development.. Nat Commun 12(1):4371 PMID: 34272364
- 7. Chen XY et al.. 2026. The mitochondria enzyme OGDH defends against disulfidptosis by licensing METTL3-regulated NRF2 translation.. Nat Cell Biol 28(9):1814-1829 PMID: 42567988
- 8. Zhuang F et al.. 2025. MALSU1-mediated regulation of mitochondrial function governs proliferation and doxorubicin resistance in triple-negative breast cancer cells.. Mol Cell Biochem 480(2):1197-1207 PMID: 38896203
